Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 13/20 | 0.47 |
| ▸ | DRD2 | P14416 | 5/20 | 0.47 |
| ▸ | DRD3 | P35462 | 4/20 | 0.47 |
| ▸ | CNR2 | P34972 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MOGAT2 | Q3SYC2 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31386365 | 0.89 | DRD4 (0.50) | DRD4DRD2DRD3CNR2MOGAT2 | |
| SCHEMBL31386108 | 0.86 | CNR2 (0.50) | DRD4DRD2DRD3CNR2MEN1 | |
| SCHEMBL31386068 | 0.86 | CNR2 (0.50) | DRD4DRD2DRD3CNR2MEN1 | |
| SCHEMBL29318596 | 0.79 | DRD4 (0.51) | DRD4DRD2DRD3CNR2MOGAT2 | |
| SCHEMBL31385790 | 0.77 | CNR2 (0.51) | DRD4DRD2DRD3CNR2MOGAT2 | |
| SCHEMBL31386000 | 0.77 | CNR2 (0.51) | DRD4DRD2DRD3CNR2MOGAT2 | |
| SCHEMBL31385848 | 0.76 | CNR2 (0.46) | DRD4DRD2CNR2MOGAT2 | |
| SCHEMBL31385875 | 0.76 | CNR2 (0.47) | DRD4DRD2DRD3CNR2MOGAT2 | |
| SCHEMBL31385748 | 0.75 | MEN1 (0.42) | DRD4DRD2DRD3MEN1KMT2A | |
| SCHEMBL1437952 | 0.74 | CNR2 (0.53) | DRD4DRD2DRD3CNR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727591-A1 | SMARCA2 DEGRADERS AND USES THEREOF | Astrazeneca AB (SE) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024256988-A1 | SMARCA2 DEGRADERS AND USES THEREOF | ASTRAZENECA AB (SE) | 2024-12-19 | — | — | WO | disclosed |